BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22718798)

  • 1. Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.
    Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; San RJ; Soriano V; Sánchez-Parra C; Sainz T; Fernández-Cruz A
    Eur J Prev Cardiol; 2014 Jun; 21(6):739-48. PubMed ID: 22718798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.
    De Socio GV; Martinelli C; Ricci E; Orofino G; Valsecchi L; Vitiello P; Martinelli L; Quirino T; Maggi P; Bonfanti P;
    Int J STD AIDS; 2010 Apr; 21(4):267-72. PubMed ID: 20378899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical factors and biomarkers associated with subclinical atherosclerosis in the human immunodeficiency virus infection].
    Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; Sánchez-Parra C; Sainz T; de Carranza M; Fernández-Cruz A
    Med Clin (Barc); 2012 Sep; 139(6):231-7. PubMed ID: 22440139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonconcordance between subclinical atherosclerosis and the calculated Framingham risk score in HIV-infected patients: relationships with serum markers of oxidation and inflammation.
    Parra S; Coll B; Aragonés G; Marsillach J; Beltrán R; Rull A; Joven J; Alonso-Villaverde C; Camps J
    HIV Med; 2010 Apr; 11(4):225-31. PubMed ID: 19845792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk assessment in HIV-infected male patients: a comparison of Framingham, SCORE, PROCAM and DAD risk equations.
    Pirš M; Jug B; Eržen B; Šabović M; Karner P; Poljak M; Tomažič J
    Acta Dermatovenerol Alp Pannonica Adriat; 2014; 23(3):43-7. PubMed ID: 25242159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Framingham risk score and early markers of atherosclerosis in a cohort of adults infected with HIV.
    Falcone EL; Mangili A; Skinner S; Alam A; Polak JF; Wanke CA
    Antivir Ther; 2011; 16(1):1-8. PubMed ID: 21311103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carotid Intima Media Thickness in Mainly Female HIV-Infected Subjects in Rural South Africa: Association With Cardiovascular but Not HIV-Related Factors.
    Schoffelen AF; de Groot E; Tempelman HA; Visseren FL; Hoepelman AI; Barth RE
    Clin Infect Dis; 2015 Nov; 61(10):1606-14. PubMed ID: 26215596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.
    Mosepele M; Hemphill LC; Palai T; Nkele I; Bennett K; Lockman S; Triant VA
    PLoS One; 2017; 12(2):e0172897. PubMed ID: 28235058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclinical atherosclerosis in low Framingham risk HIV patients.
    León R; Reus S; López N; Portilla I; Sánchez-Payá J; Giner L; Boix V; Merino E; Torrús D; Moreno-Pérez Ó; Portilla J
    Eur J Clin Invest; 2017 Aug; 47(8):591-599. PubMed ID: 28664622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carotid atherosclerosis in virologically suppressed HIV patients: comparison with a healthy sample and prediction by cardiovascular risk equations.
    Saumoy M; Di Yacovo S; Pérez S; Sánchez-Quesada JL; Valdivielso JM; Subirana I; Imaz A; Tiraboschi JM; García B; Ordoñez-LLanos J; Benítez S; Podzamczer D; Grau M
    HIV Med; 2021 Aug; 22(7):581-591. PubMed ID: 33817938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global cardiovascular risk in patients with HIV infection: concordance and differences in estimates according to three risk equations (Framingham, SCORE, and PROCAM).
    Knobel H; Jericó C; Montero M; Sorli ML; Velat M; Guelar A; Saballs P; Pedro-Botet J
    AIDS Patient Care STDS; 2007 Jul; 21(7):452-7. PubMed ID: 17651026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of Subclinical Atherosclerosis in Brazilian HIV-Infected Patients.
    Salmazo PS; Bazan SGZ; Shiraishi FG; Bazan R; Okoshi K; Hueb JC
    Arq Bras Cardiol; 2018 May; 110(5):402-410. PubMed ID: 29641646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis.
    Würtz P; Raiko JR; Magnussen CG; Soininen P; Kangas AJ; Tynkkynen T; Thomson R; Laatikainen R; Savolainen MJ; Laurikka J; Kuukasjärvi P; Tarkka M; Karhunen PJ; Jula A; Viikari JS; Kähönen M; Lehtimäki T; Juonala M; Ala-Korpela M; Raitakari OT
    Eur Heart J; 2012 Sep; 33(18):2307-16. PubMed ID: 22450427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy.
    Calza L; Borderi M; Granozzi B; Malosso P; Pancaldi L; Bon I; Re MC
    HIV Res Clin Pract; 2019 Dec; 20(6):131-139. PubMed ID: 32065065
    [No Abstract]   [Full Text] [Related]  

  • 15. Impact of preclinical carotid atherosclerosis on global cardiovascular risk stratification and events in a 10-year follow-up: comparison between the algorithms of the Framingham Heart Study, the European SCORE and the Italian 'Progetto Cuore'.
    Novo S; Carità P; Lo Voi A; Muratori I; Tantillo R; Corrado E; Kalodiki E; Novo G
    J Cardiovasc Med (Hagerstown); 2019 Feb; 20(2):91-96. PubMed ID: 30557211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical atherosclerosis and associated risk factors among HIV-infected adults in Jos, North Central Nigeria: a cross-sectional study.
    Imoh LC; Ani CC; Iyua KO; Odo AI; Amusa GA; Osaigbovo GO; Isichei CO; Agbaji OO; Imade G; Zoakah AI; Okeahialam BN; Sagay AS
    Pan Afr Med J; 2020; 37():388. PubMed ID: 33796201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alteration of type I interferon response is associated with subclinical atherosclerosis in virologically suppressed HIV-1-infected male patients.
    Santinelli L; De Girolamo G; Borrazzo C; Vassalini P; Pinacchio C; Cavallari EN; Statzu M; Frasca F; Scordio M; Bitossi C; Viscido A; Ceccarelli G; Mancone M; Mastroianni CM; Antonelli G; d'Ettorre G; Scagnolari C
    J Med Virol; 2021 Aug; 93(8):4930-4938. PubMed ID: 33913525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between the Framingham Risk Score and Carotid Artery Intima-Media Thickness in Patients With Human Immunodeficiency Virus.
    Sumayin Ngamdu K; Adewale OO; Mallawaarachchi I; Alozie OK; Dwivedi AK; Bhatt DL
    Am J Cardiol; 2020 Jul; 127():156-162. PubMed ID: 32466846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals.
    Piconi S; Parisotto S; Rizzardini G; Passerini S; Meraviglia P; Schiavini M; Niero F; Biasin M; Bonfanti P; Ricci ED; Trabattoni D; Clerici M
    AIDS; 2013 Jan; 27(3):381-9. PubMed ID: 23079800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.